(Q49161521)

English

Behavioural effects of acute and chronic β-phenylethylamine administration in the rat: Evidence for the involvement of 5-hydroxytryptamine

scientific article published on November 1, 1981

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

Behavioural effects of acute and chronic β-phenylethylamine administration in the rat: Evidence for the involvement of 5-hydroxytryptamine (English)

reason for preferred rank

most precise value

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Behavioural effects of acute and chronic beta-phenylethylamine administration in the rat: evidence for the involvement of 5-hydroxytryptamine (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7322283

4 May 2024

Colin T Dourish

1

object named as

C. T. Dourish

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7322283

4 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7322283

4 May 2024

publication date

1 November 1981

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

full work available at URL

https://api.elsevier.com/content/article/PII:0028390881900988?httpAccept=text/xml

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

https://api.elsevier.com/content/article/PII:0028390881900988?httpAccept=text/plain

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Neuropharmacology

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

20

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

11

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

1067-1072

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

A model for the quantitative study of central dopaminergic and serotoninergic activity

1

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

A new animal model for schizophrenia: interactions with adrenergic mechanisms

2

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Chronic phenylethylamine stereotypy in rats: A new animal model for schizophrenia?

3

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine

7

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Comparative effects of substituted phenylethylamines on brain serotonergic mechanisms

8

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA

10

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain.

11

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Differential antagonism by neuroleptics of backward-walking and other behaviours caused by amphetamine at high dosage

13

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan

14

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

The effect of beta-phenethylamine on noradrenaline concentrations in guinea-pig brain

16

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

The effect of -phenethylamine upon spontaneous motor activity in mice: a dual effect on locomotor activity

17

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Effect of two dopamine receptor blockers on a serotonin-mediated behavioral syndrome in rats

19

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

An animal behavior model for studying central serotonergic synapses

20

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?

22

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Behavioural changes induced by N,N-dimethyl-tryptamine in rodents

23

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Serotonergic involvement in behavioural responses to amphetamine at high dosage

24

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Serotonergic component of neuroleptic receptors

25

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

The central antiserotonergic action of mianserin

26

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

The dopamine hypothesis of schizophrenia: a review

27

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Minireview A systematic study of the pharmacological activities of dopamine antagonists

30

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Phenylethylamine in paranoid chronic schizophrenia

31

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

DOPA and other naturally occurring substances as causes of stereotypy and rage in rats

32

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Serotonergic properties of beta-phenethylamine in rats

33

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

37

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Drugs, neurotransmitters, and schizophrenia

38

1 reference

10.1016/0028-3908(81)90098-8

https://api.crossref.org/works/10.1016/0028-3908(81)90098-8

4 May 2024

Identifiers

10.1016/0028-3908(81)90098-8

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/7322283

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49161521&oldid=2144318379"